[Non-pharmacological prevention of chronic kidney disease].

Revue medicale de Liege Pub Date : 2024-06-01
Guillaume Merckx, Mélanie Somja, Gwendoline Makalou, François Jouret
{"title":"[Non-pharmacological prevention of chronic kidney disease].","authors":"Guillaume Merckx, Mélanie Somja, Gwendoline Makalou, François Jouret","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Preventing chronic kidney disease (CKD) is a major public health objective. CKD leads to significant cardiovascular morbidity and mortality, with a negative impact on quality of life and significant societal repercussions. Several drugs are effective in preventing and curbing CKD, including blockers of the renin/angiotensin/aldosterone system and inhibitors of the SGLT2 co-transporter. New molecules are currently in clinical trials focusing on the nephro-protection, such as non-steroidal mineralocorticoid receptor antagonists and GPL-1 receptor agonists. In addition to this drug arsenal, CKD prevention also relies on non-pharmacological optimization of hygienic-dietary measures, including smoking avoidance, physical activity and dietetics. The aim of this article is to detail this non-medicinal approach to the prevention and slow down of CKD.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"79 5-6","pages":"411-417"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale de Liege","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Preventing chronic kidney disease (CKD) is a major public health objective. CKD leads to significant cardiovascular morbidity and mortality, with a negative impact on quality of life and significant societal repercussions. Several drugs are effective in preventing and curbing CKD, including blockers of the renin/angiotensin/aldosterone system and inhibitors of the SGLT2 co-transporter. New molecules are currently in clinical trials focusing on the nephro-protection, such as non-steroidal mineralocorticoid receptor antagonists and GPL-1 receptor agonists. In addition to this drug arsenal, CKD prevention also relies on non-pharmacological optimization of hygienic-dietary measures, including smoking avoidance, physical activity and dietetics. The aim of this article is to detail this non-medicinal approach to the prevention and slow down of CKD.

[慢性肾病的非药物预防]。
预防慢性肾脏病(CKD)是一项重要的公共卫生目标。慢性肾脏病会导致严重的心血管疾病发病率和死亡率,对生活质量造成负面影响,并对社会产生重大影响。有几种药物可以有效预防和遏制 CKD,包括肾素/血管紧张素/醛固酮系统阻断剂和 SGLT2 共转运体抑制剂。目前正在进行临床试验的新分子主要侧重于肾脏保护,如非类固醇矿皮质激素受体拮抗剂和 GPL-1 受体激动剂。除了这些药物之外,预防慢性肾脏病还有赖于对卫生饮食措施的非药物优化,包括避免吸烟、体育锻炼和饮食习惯。本文旨在详细介绍这种预防和减缓慢性肾脏病的非药物方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信